AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-98
Results: 1-25/98
LONG-TERM SURVIVAL AFTER HEPATIC RESECTION FOR METASTATIC BREAST-CANCER - A CASE-REPORT
Authors: DEBOER RH SMITH IE SACKS NPM
Citation: Rh. Deboer et al., LONG-TERM SURVIVAL AFTER HEPATIC RESECTION FOR METASTATIC BREAST-CANCER - A CASE-REPORT, European journal of cancer, 34(11), 1998, pp. 1815-1815
CONTINUOUS INFUSIONAL CHEMOTHERAPY AS PREOPERATIVE AND AS ADJUVANT TREATMENT IN EARLY BREAST-CANCER
Authors: SMITH IE
Citation: Ie. Smith, CONTINUOUS INFUSIONAL CHEMOTHERAPY AS PREOPERATIVE AND AS ADJUVANT TREATMENT IN EARLY BREAST-CANCER, European journal of cancer, 34, 1998, pp. 31-31
A RANDOMIZED STUDY OF SRL172 (MYCOBACTERIUM VACCAE) IN PATIENTS WITH ADVANCED LUNG-CANCER TREATED WITH CHEMOTHERAPY
Authors: WEBB A ALMOUNDHRI M SOUBERBIELLE BE NORTON A PRIEST K RYAN C MENDES R ASHLEY S SMITH IE OBRIEN MER
Citation: A. Webb et al., A RANDOMIZED STUDY OF SRL172 (MYCOBACTERIUM VACCAE) IN PATIENTS WITH ADVANCED LUNG-CANCER TREATED WITH CHEMOTHERAPY, Annals of oncology, 9, 1998, pp. 421-421
GOOD SYMPTOM RELIEF WITH PALLIATIVE MVP (MITOMYCIN-C, VINBLASTINE ANDCISPLATIN) CHEMOTHERAPY IN MALIGNANT MESOTHELIOMA
Authors: MIDDLETON GW SMITH IE OBRIEN MER NORTON A HICKISH T PRIEST K SPENCER L ASHLEY S
Citation: Gw. Middleton et al., GOOD SYMPTOM RELIEF WITH PALLIATIVE MVP (MITOMYCIN-C, VINBLASTINE ANDCISPLATIN) CHEMOTHERAPY IN MALIGNANT MESOTHELIOMA, Annals of oncology, 9(3), 1998, pp. 269-273
TREATMENT OF VENTILATORY FAILURE IN THE PRADER-WILLI-SYNDROME
Authors: SMITH IE KING MA SIKLOS PWL SHNEERSON JM
Citation: Ie. Smith et al., TREATMENT OF VENTILATORY FAILURE IN THE PRADER-WILLI-SYNDROME, The European respiratory journal, 11(5), 1998, pp. 1150-1152
MASK INTERMITTENT POSITIVE PRESSURE VENTILATION IN CHRONIC HYPERCAPNIC RESPIRATORY-FAILURE DUE TO CHRONIC OBSTRUCTIVE PULMONARY-DISEASE
Authors: SIVASOTHY P SMITH IE SHNEERSON JM
Citation: P. Sivasothy et al., MASK INTERMITTENT POSITIVE PRESSURE VENTILATION IN CHRONIC HYPERCAPNIC RESPIRATORY-FAILURE DUE TO CHRONIC OBSTRUCTIVE PULMONARY-DISEASE, The European respiratory journal, 11(1), 1998, pp. 34-40
PIVOTAL TRIALS OF LETROZOLE - A NEW AROMATASE INHIBITOR
Authors: SMITH IE
Citation: Ie. Smith, PIVOTAL TRIALS OF LETROZOLE - A NEW AROMATASE INHIBITOR, Oncology, 12(3), 1998, pp. 41-44
PRIMARY CHEMOTHERAPY IN BREAST-CANCER
Authors: SMITH IE ALMOUNDHRI M
Citation: Ie. Smith et M. Almoundhri, PRIMARY CHEMOTHERAPY IN BREAST-CANCER, Biomedicine & pharmacotherapy, 52(3), 1998, pp. 116-121
RANDOMIZED PHASE-II TRIAL OF INFUSIONAL FLUOROURACIL, EPIRUBICIN, ANDCYCLOPHOSPHAMIDE VERSUS INFUSIONAL FLUOROURACIL, EPIRUBICIN, AND CISPLATIN IN PATIENTS WITH ADVANCED BREAST-CANCER
Authors: EISEN T SMITH IE JOHNSTON S ELLIS PA PRENDIVILLE J SEYMOUR MT WALSH G ASHLEY S
Citation: T. Eisen et al., RANDOMIZED PHASE-II TRIAL OF INFUSIONAL FLUOROURACIL, EPIRUBICIN, ANDCYCLOPHOSPHAMIDE VERSUS INFUSIONAL FLUOROURACIL, EPIRUBICIN, AND CISPLATIN IN PATIENTS WITH ADVANCED BREAST-CANCER, Journal of clinical oncology, 16(4), 1998, pp. 1350-1357
PHASE-II TRIAL OF TOPOTECAN ADMINISTERED AS A 21-DAY CONTINUOUS-INFUSION IN PREVIOUSLY UNTREATED PATIENTS WITH STAGE IIIB AND IV NON-SMALL-CELL LUNG-CANCER
Authors: KINDLER HL KRIS MG SMITH IE MILLER VA GRANT SC KREBS JB ROSS GA SLEVIN ML
Citation: Hl. Kindler et al., PHASE-II TRIAL OF TOPOTECAN ADMINISTERED AS A 21-DAY CONTINUOUS-INFUSION IN PREVIOUSLY UNTREATED PATIENTS WITH STAGE IIIB AND IV NON-SMALL-CELL LUNG-CANCER, American journal of clinical oncology, 21(5), 1998, pp. 438-441
ANALYSIS AND SORTING OF APOPTOTIC CELLS FROM FINE-NEEDLE ASPIRATES OFEXCISED HUMAN PRIMARY BREAST CARCINOMAS
Authors: DOWSETT M DETRE S ORMEROD MG ELLIS PA MAINWARING PN TITLEY JC SMITH IE
Citation: M. Dowsett et al., ANALYSIS AND SORTING OF APOPTOTIC CELLS FROM FINE-NEEDLE ASPIRATES OFEXCISED HUMAN PRIMARY BREAST CARCINOMAS, Cytometry, 32(4), 1998, pp. 291-300
FADROZOLE AND LETROZOLE IN ADVANCED BREAST-CANCER - CLINICAL AND BIOCHEMICAL EFFECTS
Authors: SMITH IE NORTON A
Citation: Ie. Smith et A. Norton, FADROZOLE AND LETROZOLE IN ADVANCED BREAST-CANCER - CLINICAL AND BIOCHEMICAL EFFECTS, Breast cancer research and treatment, 49, 1998, pp. 67-71
REDUCED APOPTOSIS AND PROLIFERATION AND INCREASED BCL-2 IN RESIDUAL BREAST-CANCER FOLLOWING PREOPERATIVE CHEMOTHERAPY
Authors: ELLIS PA SMITH IE DETRE S BURTON SA SALTER J AHERN R WALSH G JOHNSTON SRD DOWSETT M
Citation: Pa. Ellis et al., REDUCED APOPTOSIS AND PROLIFERATION AND INCREASED BCL-2 IN RESIDUAL BREAST-CANCER FOLLOWING PREOPERATIVE CHEMOTHERAPY, Breast cancer research and treatment, 48(2), 1998, pp. 107-116
COMPARISON OF IN-SITU METHODS TO ASSESS DNA CLEAVAGE IN APOPTOTIC CELLS IN PATIENTS WITH BREAST-CANCER
Authors: MAINWARING PN ELLIS PA DETRE S SMITH IE DOWSETT M
Citation: Pn. Mainwaring et al., COMPARISON OF IN-SITU METHODS TO ASSESS DNA CLEAVAGE IN APOPTOTIC CELLS IN PATIENTS WITH BREAST-CANCER, Journal of Clinical Pathology, 51(1), 1998, pp. 34-37
PREOPERATIVE CHEMOTHERAPY IN EARLY-STAGE RESECTABLE NON-SMALL-CELL LUNG-CANCER - A RANDOMIZED FEASIBILITY STUDY JUSTIFYING A MULTICENTER PHASE-III TRIAL
Authors: DEBOER RH GOLDSTRAW P PASTORINO U OBRIEN MER RAMAGE F ASHLEY S SMITH IE
Citation: Rh. Deboer et al., PREOPERATIVE CHEMOTHERAPY IN EARLY-STAGE RESECTABLE NON-SMALL-CELL LUNG-CANCER - A RANDOMIZED FEASIBILITY STUDY JUSTIFYING A MULTICENTER PHASE-III TRIAL, British Journal of Cancer, 78, 1998, pp. 4-4
A RANDOMIZED STUDY OF SRL172 (MYCOBACTERIUM-VACCAE) IN PATIENTS WITH ADVANCED LUNG-CANCER TREATED WITH CHEMOTHERAPY
Authors: WEBB A ALMOUNDHRI M SOUBERBIELLE BE NORTON A PRIEST K RYAN C MENDES R ASHLEY S SMITH IE OBRIEN MER
Citation: A. Webb et al., A RANDOMIZED STUDY OF SRL172 (MYCOBACTERIUM-VACCAE) IN PATIENTS WITH ADVANCED LUNG-CANCER TREATED WITH CHEMOTHERAPY, British Journal of Cancer, 78, 1998, pp. 5-5
A RANDOMIZED STUDY COMPARING 3-WEEKLY EPIRUBICIN, CYCLOPHOSPHAMIDE AND CONTINUOUS-INFUSION 5-FU (ECF) TO A 2-WEEKLY SCHEDULE WITH G-CSF IN ADVANCED BREAST-CANCER
Authors: DEBOER RH EISEN TG ELLIS PA JOHNSTON SRD WALSH G SMITH IE
Citation: Rh. Deboer et al., A RANDOMIZED STUDY COMPARING 3-WEEKLY EPIRUBICIN, CYCLOPHOSPHAMIDE AND CONTINUOUS-INFUSION 5-FU (ECF) TO A 2-WEEKLY SCHEDULE WITH G-CSF IN ADVANCED BREAST-CANCER, British Journal of Cancer, 78, 1998, pp. 40-40
BIOMARKERS FOR THE PREDICTION OF COMPLETE CLINICAL-RESPONSE TO PRIMARY CHEMOTHERAPY IN EARLY BREAST-CANCER
Authors: ARCHER CD ASHLEY S DOWSETT M SMITH IE
Citation: Cd. Archer et al., BIOMARKERS FOR THE PREDICTION OF COMPLETE CLINICAL-RESPONSE TO PRIMARY CHEMOTHERAPY IN EARLY BREAST-CANCER, British Journal of Cancer, 78, 1998, pp. 44-44
CLINICAL BENEFIT FROM PALLIATIVE CHEMOTHERAPY IN NONSMALL CELL LUNG-CANCER EXTENDS TO THE ELDERLY AND THOSE WITH POOR PROGNOSTIC FACTORS
Authors: HICKISH TF SMITH IE OBRIEN MER ASHLEY S MIDDLETON G
Citation: Tf. Hickish et al., CLINICAL BENEFIT FROM PALLIATIVE CHEMOTHERAPY IN NONSMALL CELL LUNG-CANCER EXTENDS TO THE ELDERLY AND THOSE WITH POOR PROGNOSTIC FACTORS, British Journal of Cancer, 78(1), 1998, pp. 28-33
EXPRESSION OF EPIDERMAL GROWTH-FACTOR RECEPTOR AND C-ERBB2 DURING THEDEVELOPMENT OF TAMOXIFEN RESISTANCE IN HUMAN BREAST-CANCER
Authors: NEWBY JC JOHNSTON SRD SMITH IE DOWSETT M
Citation: Jc. Newby et al., EXPRESSION OF EPIDERMAL GROWTH-FACTOR RECEPTOR AND C-ERBB2 DURING THEDEVELOPMENT OF TAMOXIFEN RESISTANCE IN HUMAN BREAST-CANCER, Clinical cancer research, 3(9), 1997, pp. 1643-1651
MORE MONEY IS NEEDED TO CARE FOR PATIENTS WITH CANCER
Authors: LEONARD RCF SMITH IE COLEMAN RE MALPAS JS NICOLSON M CASSIDY J JONES A MCILLMURRAY MB STUART NSA WOLL PJ WHITEHOUSE JMA
Citation: Rcf. Leonard et al., MORE MONEY IS NEEDED TO CARE FOR PATIENTS WITH CANCER, BMJ. British medical journal, 315(7111), 1997, pp. 811-812
PRIMARY CHEMOTHERAPY FOR EARLY BREAST-CANCER - A REVOLUTION IN PROGRESS
Authors: SMITH IE
Citation: Ie. Smith, PRIMARY CHEMOTHERAPY FOR EARLY BREAST-CANCER - A REVOLUTION IN PROGRESS, European journal of cancer, 33, 1997, pp. 594-594
ROLE OF RECOMBINANT INTERFERON-GAMMA MAINTENANCE IN RESPONDING PATIENTS WITH SMALL-CELL LUNG-CANCER - A RANDOMIZED PHASE-III STUDY OF THE EORTC LUNG-CANCER COOPERATIVE GROUP
Authors: VANZANDWIJK N GROEN HJM POSTMUS PE BURGHOUTS JTW TENVELDE GPM ARDIZZONI A SMITH IE BAAS P SAHMOUD T KIRKPATRICK A DALESIO O GIACCONE G
Citation: N. Vanzandwijk et al., ROLE OF RECOMBINANT INTERFERON-GAMMA MAINTENANCE IN RESPONDING PATIENTS WITH SMALL-CELL LUNG-CANCER - A RANDOMIZED PHASE-III STUDY OF THE EORTC LUNG-CANCER COOPERATIVE GROUP, European journal of cancer, 33(11), 1997, pp. 1759-1766
MULTICORE MYOPATHY PRESENTING IN ADULTHOOD WITH RESPIRATORY-FAILURE
Authors: ZEMAN AZJ DICK DJ ANDERSON JR WATKIN SW SMITH IE SHNEERSON JM
Citation: Azj. Zeman et al., MULTICORE MYOPATHY PRESENTING IN ADULTHOOD WITH RESPIRATORY-FAILURE, Muscle & nerve, 20(3), 1997, pp. 367-369
A COMPARISON OF CHILDREN AFFECTED BY PRENATAL ALCOHOL EXPOSURE AND ATTENTION-DEFICIT, HYPERACTIVITY DISORDER
Authors: COLES CD PLATZMAN KA RASKINDHOOD CL BROWN RT FALEK A SMITH IE
Citation: Cd. Coles et al., A COMPARISON OF CHILDREN AFFECTED BY PRENATAL ALCOHOL EXPOSURE AND ATTENTION-DEFICIT, HYPERACTIVITY DISORDER, Alcoholism, clinical and experimental research, 21(1), 1997, pp. 150-161
Risultati: 1-25 | 26-50 | 51-75 | 76-98